ABBOTT DRNABBOTT DRNABBOTT DRN

ABBOTT DRN

No trades
See on Supercharts

Key facts today

Barclays has revised the price target for Abbott Laboratories to $149 from $143, maintaining an average rating of outperform. Analysts have set price targets for the company ranging from $104 to $149.
Analyze the impactAnalyze the impact
Market capitalization
‪1.21 T‬BRL
0.00BRL
‪28.48 B‬BRL
‪200.34 B‬BRL
Beta (1Y)
−0.03

About Abbott Laboratories


CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
ISIN
BRABTTBDR007
FIGI
BBG002Q24FQ6
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
S
ABT3985539
St. Jude Medical, LLC 4.75% 15-APR-2043
Yield to maturity
6.61%
Maturity date
Apr 15, 2043
US2824BH2
ABBOTT LABS 16/46
Yield to maturity
5.18%
Maturity date
Nov 30, 2046
ABT.GX
Abbott Laboratories 6.0% 01-APR-2039
Yield to maturity
5.12%
Maturity date
Apr 1, 2039
ABT.HB
Abbott Laboratories 5.3% 27-MAY-2040
Yield to maturity
5.08%
Maturity date
May 27, 2040
ABT.GW
Abbott Laboratories 6.15% 30-NOV-2037
Yield to maturity
5.05%
Maturity date
Nov 30, 2037
ABT4466215
Abbott Laboratories 4.75% 15-APR-2043
Yield to maturity
5.04%
Maturity date
Apr 15, 2043
ABLC
ABBOTT LABS 16/36
Yield to maturity
4.99%
Maturity date
Nov 30, 2036
S
ABT4289257
St. Jude Medical, LLC 3.875% 15-SEP-2025
Yield to maturity
4.59%
Maturity date
Sep 15, 2025
US2824BQ2
ABBOTT LAB 20/30
Yield to maturity
4.41%
Maturity date
Jun 30, 2030
US2824BF6
ABBOTT LABS 16/26
Yield to maturity
4.39%
Maturity date
Nov 30, 2026
ABT5005071
Abbott Laboratories 1.15% 30-JAN-2028
Yield to maturity
4.26%
Maturity date
Jan 30, 2028

Explore more bonds